The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Two-Year Outcome in First-Episode Schizophrenia: Predictive Value of Symptoms for Quality of Life
Abstract
OBJECTIVE: Many studies have validated the grouping of schizophrenic symptoms into three independent dimensions: negative, psychotic, and disorganized. Negative symptoms are considered to be an important prognostic indicator, but this clinical observation requires further empirical study, especially with respect to psychosocial functioning. When present at the onset of the first episode, negative symptoms suggest that the patient will develop significant psychosocial impairment. The predictive values of the psychotic and disorganized symptom dimensions, on the other hand, have been less certain. METHOD: In this study of 50 first-episode schizophrenic patients, who were mostly neuroleptic-naive at intake, the authors examined the relationship between the severity of these three symptom dimensions (measured by using the Scale for the Assessment of Negative Symptoms and the Scale for the Assessment of Positive Symptoms) at index hospitalization and quality of life at 2-year follow-up. RESULTS: Negative symptom severity was positively and significantly correlated with later occupational impairment, financial dependence on others, impaired relationships with friends, impaired ability to enjoy recreational activities, and global assessment of functioning. The magnitudes of correlation between the levels of psychotic symptoms or disorganized symptoms and 2-year quality of life measures were comparatively lower. Analyses using multivariate regression statistics also revealed similar findings. CONCLUSIONS: Severity of negative symptoms at index hospitalization may be a portent of poor outcome. In general, severity of psychotic or disorganized symptoms at intake does not appear to predict subsequent quality of life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Global Assessment Scale: A Procedure for Measuring Overall Severity of Psychiatric Disturbance
Endicott, J. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770060086012 · Cited by 4,982
The Symptoms of Chronic Schizophrenia: A Re-examination of the Positive-Negative Dichotomy
Liddle, P. F. (1987) · British Journal of Psychiatry · doi:10.1192/bjp.151.2.145 · Cited by 1,427
Andreasen, N. C. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820080023004 · Cited by 1,323
Self-citationRisperidone in the treatment of schizophrenia
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.6.825 · Cited by 1,193
Duration of psychosis and outcome in first-episode schizophrenia
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.9.1183 · Cited by 880
CHOUINARD, G., JONES, B., REMINGTON, G., BLOOM, D., ADDINGTON, D., MacEWAN, G. W., LABELLE, A., BEAUCLAIR, L., & ARNOTT, W. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199302000-00004 · Cited by 876
Olanzapine versus Placebo and Haloperidol
Beasley, C. M., Tollefson, G., Tran, P., Satterlee, W., Sanger, T., & Hamilton, S. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00069-p · Cited by 778
Symptoms of Schizophrenia: Methods, Meanings, and Mechanisms
Andreasen, N. C. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950170015003 · Cited by 734
Self-citationBreier, A. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810270051007 · Cited by 626
Prediction of Outcome in Schizophrenia: III. Five-Yearn Outcome and Its Predictors
Strauss, J. S. (1977) · Archives of General Psychiatry · doi:10.1001/archpsyc.1977.01770140049005 · Cited by 521
Cited by
Milev, P., Ho, B.-C., Arndt, S., & Andreasen, N. C. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.3.495 · Cited by 920
Self-citationGlutamate and dopamine in schizophrenia: An update for the 21 st century
Howes, O., McCutcheon, R., & Stone, J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114563634 · Cited by 702
Negative Symptoms in Schizophrenia: Avolition and Occam's Razor
Foussias, G., & Remington, G. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn094 · Cited by 594
“Negative symptoms and functional outcomes have consistently been linked, with several studies reporting worse functional outcomes in individuals with more prominent negative symptoms.(36,42,72,73) More specifically, these studies have demonstrated correlations between negative symptoms and impairments in occupational…”
BackgroundResultRobinson, D. G., Woerner, M. G., McMeniman, M., Mendelowitz, A., & Bilder, R. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.3.473 · Cited by 590
Ventura, J., Hellemann, G. S., Thames, A. D., Koellner, V., & Nuechterlein, K. H. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.03.035 · Cited by 560
Barch, D. M., & Dowd, E. C. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq068 · Cited by 477
Galderisi, S., Rossi, A., Rocca, P., Bertolino, A., Mucci, A., Bucci, P., Rucci, P., Gibertoni, D., Aguglia, E., Amore, M., et al. (2014) · World Psychiatry · doi:10.1002/wps.20167 · Cited by 463
Psychiatric Symptoms and Quality of Life in Schizophrenia: A Meta-Analysis
Eack, S. M., & Newhill, C. E. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl071 · Cited by 437
Anhedonia in Schizophrenia: A Review of Assessment Strategies
Horan, W. P., Kring, A. M., & Blanchard, J. J. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj009 · Cited by 337
A systematic review of longitudinal outcome studies of first-episode psychosis
MENEZES, N. M., ARENOVICH, T., & ZIPURSKY, R. B. (2006) · Psychological Medicine · doi:10.1017/s0033291706007951 · Cited by 333
First-Episode Psychosis: Psychopathology, Quality of Life, and Functional Outcome
Malla, A. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi031 · Cited by 288
Santesteban-Echarri, O., Paino, M., Rice, S., González-Blanch, C., McGorry, P., Gleeson, J., & Alvarez-Jimenez, M. (2017) · Clinical Psychology Review · doi:10.1016/j.cpr.2017.09.007 · Cited by 268
Cannabis Use and Age at Onset of Schizophrenia
Veen, N. D., Selten, J.-P., van der Tweel, I., Feller, W. G., Hoek, H. W., & Kahn, R. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.3.501 · Cited by 266
Ho, B.-C., Andreasen, N. C., Flaum, M., Nopoulos, P., & Miller, D. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.808 · Cited by 259
Self-citationBlanchard, J. J., Kring, A. M., Horan, W. P., & Gur, R. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq104 · Cited by 239
Lutgens, D., Gariepy, G., & Malla, A. (2017) · British Journal of Psychiatry · doi:10.1192/bjp.bp.116.197103 · Cited by 181
White, R., Gumley, A., McTaggart, J., Rattrie, L., McConville, D., Cleare, S., & Mitchell, G. (2011) · Behaviour Research and Therapy · doi:10.1016/j.brat.2011.09.003 · Cited by 161
Perceived quality of life in schizophrenia: Relationships to sleep quality
Ritsner, M., Kurs, R., Ponizovsky, A., & Hadjez, J. (2004) · Quality of Life Research · doi:10.1023/b:qure.0000021687.18783.d6 · Cited by 156
“Factors associated with poor QOL of schizophrenia patients can be summarized as follows: negative symptoms [8, 9], general psychopathology [10, 11], depressive symptoms [6], emotional and somatic distress [12, 13], medication side effects [14], duration of illness and hospitalizations [15].”
Apathy in schizophrenia: clinical correlates and association with functional outcome
Kiang, M., Christensen, B. K., Remington, G., & Kapur, S. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00433-4 · Cited by 118
Negative symptoms in first episode non‐affective psychosis
Malla, A. K., Takhar, J. J., Norman, R. M. G., Manchanda, R., Cortese, L., Haricharan, R., Verdi, M., & Ahmed, R. (2002) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2002.02139.x · Cited by 118
Advances in microstructural diffusion neuroimaging for psychiatric disorders
Pasternak, O., Kelly, S., Sydnor, V. J., & Shenton, M. E. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.04.051 · Cited by 116
Onset and clinical course of schizophrenia in Butajira-Ethiopia
Kebede, D., Alem, A., Shibre, T., Negash, A., Fekadu, A., Fekadu, D., Deyassa, N., Jacobsson, L., & Kullgren, G. (2003) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-003-0678-4 · Cited by 104
PANSS syndromes and quality of life in schizophrenia.
Karow, A., Moritz, S., Lambert, M., Schoder, S., & Krausz, M. (2005) · Psychopathology · doi:10.1159/000088921 · Cited by 97
Static posed and evoked facial expressions of emotions in schizophrenia
Kohler, C. G., Martin, E. A., Stolar, N., Barrett, F. S., Verma, R., Brensinger, C., Bilker, W., Gur, R. E., & Gur, R. C. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.05.010 · Cited by 59
Tews, B., Schönig, K., Arzt, M. E., Clementi, S., Rioult-Pedotti, M.-S., Zemmar, A., Berger, S. M., Schneider, M., Enkel, T., Weinmann, O., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217665110 · Cited by 56
“The Nogo-A knockdown rat with both positive and negative schizophrenia-like symptoms may provide a tool for testing compounds selective for negative symptoms, the severity of which is most predictive for poor therapeutic outcome in patients (38).”
MethodPriebe, S., Savill, M., Wykes, T., Bentall, R. P., Reininghaus, U., Lauber, C., Bremner, S., Eldridge, S., & Röhricht, F. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.115.171397 · Cited by 52
“2,3 Negative symptoms have been found to have a profound impact on long-term outcomes, 4,5 but current treatment options are limited.”
Self-Help Interventions for Psychosis: A Meta-Analysis
Scott, A. J., Webb, T. L., & Rowse, G. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.05.002 · Cited by 33
Metadata
- Authors
- Ho, B.-C., Nopoulos, P., Flaum, M., Arndt, S., & Andreasen, N. C.
- Venue
- American Journal of Psychiatry
- Published
- 1998-09-01
- Volume
- 155
- Issue
- 9
- Pages
- 1196-1201
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2119265191
- Cited by
- 312
- References
- 42
- FWCI
- 3.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.